Els Henckaerts

Company: Tavira Therapeutics

Job title: Co-Founder and Chief Scientific Officer

Seminars:

Exploring Enzymatic Conjugation as a Capsid Design Approach to Improve Vector Targeting 2:00 pm

Understanding the approach of enzymatically conjugating chemicals or biologics to the AAV capsid Highlighting how this rational design approach can increase tissue tropism and eliminate liver targeting Emphasizing how increasing specificity also improves potency and limits toxicityRead more

day: Conference Day One